BARCLAYS PLC - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 176 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,579
-33.5%
288,654
+14.3%
0.00%0.0%
Q2 2023$3,879
-15.0%
252,583
+24.6%
0.00%0.0%
Q1 2023$4,561
+17.4%
202,786
+9.7%
0.00%0.0%
Q4 2022$3,885
-99.9%
184,786
+35.0%
0.00%
-50.0%
Q3 2022$3,374,000
+445.1%
136,913
+435.7%
0.00%
Q2 2022$619,000
-50.9%
25,556
-47.7%
0.00%
-100.0%
Q1 2022$1,261,00048,9010.00%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 411,680$10,609,0009.85%
VR Adviser, LLC 1,994,997$51,411,0008.33%
Kynam Capital Management, LP 870,918$22,444,0007.28%
GREAT POINT PARTNERS LLC 1,010,000$26,028,0006.29%
Deep Track Capital, LP 3,134,503$80,776,0005.18%
RA Capital Management 4,922,941$126,864,0002.77%
ARMISTICE CAPITAL, LLC 4,958,000$127,768,0002.47%
MPM BioImpact LLC 277,950$7,163,0001.92%
Sofinnova Investments, Inc. 658,249$16,963,0001.29%
Perceptive Advisors 1,845,555$47,560,0000.95%
View complete list of TRAVERE THERAPEUTICS INC shareholders